Current role
Esteban Masuda
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Rigel Pharmaceuticals Inc (RIGL)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Rigel Pharmaceuticals Inc (RIGL) | Executive Vice President, Research Anne-Marie Duliege\ | $360,582 | $796,088 |
| 2018 | Rigel Pharmaceuticals Inc (RIGL) | Executive Vice President, Research Anne-Marie Duliege\ | $350,080 | $1,300,238 |
| 2017 | Rigel Pharmaceuticals Inc (RIGL) | Executive Vice President, Research Anne-Marie Duliege\ | $336,000 | $638,378 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.